| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.30▲ | 5.30▲ | 5.30▲ | 5.36▲ | 5.39▲ |
| MA10 | 5.31▲ | 5.38▼ | 5.38▼ | 5.33▲ | 5.64▼ |
| MA20 | 5.35▲ | 5.33▲ | 5.33▲ | 5.42▼ | 5.63▼ |
| MA50 | 5.43▼ | 5.55▼ | 5.49▼ | 5.63▼ | 5.59▼ |
| MA100 | 5.62▼ | 5.66▼ | 5.68▼ | 5.56▼ | N/A |
| MA200 | 5.75▼ | 5.71▼ | 5.53▼ | 5.30▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | 0.012▲ | 0.011▲ | 0.019▲ | -0.012▼ |
| RSI | 50.197▲ | 48.692▼ | 48.727▼ | 48.705▼ | 47.029▼ |
| STOCH | 42.167 | 58.333 | 58.333 | 51.131 | 34.719 |
| WILL %R | -39.000 | -39.000 | -39.000 | -70.968 | -70.064 |
| CCI | 12.304 | -24.007 | -24.007 | -49.678 | -127.567▼ |
|
Monday, August 11, 2025 01:34 PM
$5 Million in Funding: In April 2025, Serina secured $5 million from strategic shareholders to support the continued development of SER-252 (POZ-apomorphine), Serina's lead clinical candidate for ...
|
|
Wednesday, August 06, 2025 04:15 AM
Following FDA input, Seres submitted Phase 2 study protocol to FDA for SER-155 for the prevention of bloodstream infections (BSIs) in adults undergoing allogeneic hematopoietic stem cell transplant ...
|
|
Monday, March 10, 2025 05:00 PM
Here are some of the largest recent moves: CITADEL ADVISORS LLC added 13,184 shares (+inf%) to their portfolio in Q1 2025, for an estimated $74,753 MILLENNIUM MANAGEMENT LLC removed 3,830 shares ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 4.95 | 5.547 | 4.95 | 5.40 | 15,600 |
| 14/08/25 | 5.33 | 5.55 | 5.33 | 5.50 | 3,619 |
| 13/08/25 | 5.38 | 5.61 | 5.25 | 5.365 | 6,724 |
| 12/08/25 | 5.10 | 5.63 | 5.10 | 5.46 | 21,800 |
| 11/08/25 | 5.34 | 5.45 | 5.10 | 5.10 | 3,273 |
| 08/08/25 | 5.51 | 5.53 | 5.325 | 5.51 | 12,379 |
| 07/08/25 | 5.34 | 5.54 | 5.1671 | 5.45 | 11,413 |
| 06/08/25 | 5.16 | 5.52 | 5.044 | 5.26 | 9,800 |
| 05/08/25 | 5.10 | 5.189 | 5.02 | 5.15 | 12,900 |
| 04/08/25 | 5.13 | 5.35 | 5.13 | 5.1321 | 21,349 |
|
|
||||
|
|
||||
|
|